Introduction

Glenmark Life Sciences Ltd. engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes.

Observation

As we can see stock breakout ascending trading with 1 million plus trading volume. Stock RSI Looks strong Stock trade above all the ema. let retrace for better up move as shown on the chart. when whole market down 3% this secular stock will rise this is how market participant play safer when market crash or fluctuates. let me explain you what secular stock is and how it works right here👇

A secular stock is a company whose products or services are consistently in demand, regardless of the overall state of the economy or market trends.

1. Consistent revenue growth

2. Strong market position

3. Unique products or services

4. Ability to adapt to changing market conditions

5. Long-term growth potential

Pharmaceutical stocks can be considered secular because:

1. People will always need medicines and healthcare products

2. Aging populations and increasing healthcare needs drive demand

3. Innovation and new drug discoveries create growth opportunities

Other examples of secular stocks include:

1. Consumer staples (e.g., food, beverages, household products)

2. Technology (e.g., software, cybersecurity)

3. Healthcare services (e.g., hospitals, medical devices)

4. E-commerce and digital payments

Keep in mind that while secular stocks tend to be more resilient, they're not immune to market fluctuations. Always research and consider multiple factors before investing.

Let's touch fundamentals

Stock PE is 25, ROCE 28%, ROE 21%, Promotor holding pledge 9.47%, Public holding 10%, Promotor holding 83%.

Technical Analysis & indicators 🔍

Daily ChartAscending 

Triangle Pattern

News of the day

1. Oil and Natural Gas Corporation (ONGC) has intensified operations to increase gas production in Tripura to feed power generation plants in the northeastern state, an official said on Monday.The decision comes amid reports of a reduction in gas supply to various gas-based power generation plants in the state.ONGC produced 1,527 million standard cubic metres (MMSCM) of gas in Tripura in the 2023-24 fiscal, while it has set a target of extracting 1,675 MMSCM gas in the current fiscal."ONGC has been working to increase gas production so that sufficient gas is supplied to the gas-based power plants in Tripura. We have already set a target of extracting 1,675 MMSCM of gas during the current fiscal year (2024-25) while the production was 1,527 MMSCM in 2023-24," ONGC's Tripura Asset Manager Krishna Kumar told PTI.

2. Tata Motors (TTMT) reported a strong consolidated performance in 1QFY25, with margins expanding ~110bp YoY to 14.4% (est. 13.3%), driven by JLR and strong India CV business margins even as India PV margin missed estimates. Margins were also supported by higher capitalization rate (1Q at 6.2% of revenues v/s 4.6% YoY). However, apart from the risks from subdued global demand and margin headwinds at JLR, recent supplier based constraint may pose as an incremental headwind in the near-term. This, coupled with demand moderation in its India CV and PV businesses, raises concerns about TTMT’s ability to sustain the current-level of profitability going forward. We raise our EPS estimates by 3%/4% for FY25/FY26. The stock trades at 19.1x/16.4x FY25E/FY26E consol. EPS and 7x/5.7x EV/EBITDA. Reiterate Neutral with Jun’26E SOTP-based TP of INR1,025.

3. The board of Manappuram Finance will meet on Aug. 8 to consider raising funds through the issuance of non-convertible bonds, according to an Indian bourse filing on Monday. Shares of the company fell nearly 5% in recent trade.

Educational content

Tue Aug 6, 2024